MENU
+Compare
BFRI
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$0.70
Change
+$0.01 (+1.45%)
Capitalization
9.77M

BFRI Biofrontera Forecast, Technical & Fundamental Analysis

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy... Show more

BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BFRI with price predictions
Jul 03, 2025

BFRI in downward trend: price expected to drop as it breaks its higher Bollinger Band on June 30, 2025

BFRI broke above its upper Bollinger Band on June 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 22 similar instances where the stock broke above the upper band. In of the 22 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BFRI's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 44 cases where BFRI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 30, 2025. You may want to consider a long position or call options on BFRI as a result. In of 59 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BFRI just turned positive on June 03, 2025. Looking at past instances where BFRI's MACD turned positive, the stock continued to rise in of 29 cases over the following month. The odds of a continued upward trend are .

BFRI moved above its 50-day moving average on June 30, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BFRI advanced for three days, in of 156 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 68 cases where BFRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.039) is normal, around the industry mean (62.462). P/E Ratio (0.000) is within average values for comparable stocks, (88.783). BFRI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.087) is also within normal values, averaging (19.186).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BFRI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BFRI is expected to report earnings to fall 53.19% to -21 cents per share on August 11

Biofrontera BFRI Stock Earnings Reports
Q2'23
Est.
$-0.22
Q1'25
Missed
by $0.28
Q4'24
Beat
by $0.02
Q1'23
Missed
by $0.20
Q4'22
Missed
by $0.04
The last earnings report on May 15 showed earnings per share of -46 cents, missing the estimate of -18 cents. With 106.86K shares outstanding, the current market capitalization sits at 9.77M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
120 Presidential Way
Phone
+1 781 245-1325
Employees
85
Web
https://www.biofrontera-us.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRPO12.050.75
+6.67%
Precipio
HSAI21.931.20
+5.79%
Hesai Group American Depositary Share each ADS represents one
CNP35.940.17
+0.48%
CenterPoint Energy
KLIC36.76-0.02
-0.05%
Kulicke and Soffa Industries
EBS6.99-0.12
-1.69%
Emergent Biosolutions

BFRI and Stocks

Correlation & Price change

A.I.dvisor tells us that BFRI and CRON have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
+1.43%
CRON - BFRI
23%
Poorly correlated
+2.00%
COLL - BFRI
21%
Poorly correlated
-0.52%
PLSH - BFRI
17%
Poorly correlated
N/A
ALVO - BFRI
12%
Poorly correlated
+2.91%
CRDL - BFRI
12%
Poorly correlated
+10.79%
More